James Reed: all about business 24. Responding to a crisis: The force behind getting life-saving vaccines to the public | Dame Kate Bingham
The UK’s life science sector is booming, generating over £100 billion in turnover in 2022. And with more and more companies entering the space, how do you marry business and science to create a drug that not only makes money but saves lives.
In this episode of All About Business, I sit down with Dame Kate Bingham, Managing Partner at SV Health Investors, specialising in biotechnology investments. Kate has over 30 years of experience in healthcare investment and led the UK's vaccine task force during COVID-19.
She shares the ins and outs of health care investment, the challenges that came with leading the UK’s vaccine taskforce, and what she did when the press questioned her credentials.
Dame Kate Bingham is a venture capitalist and biotech investor. She is best known for her role as the chair of the UK Vaccine Taskforce during the COVID-19 pandemic, where she led efforts to procure and distribute vaccines.
Katie is currently a managing partner at SV Health Investors, specialising in biotechnology investments.
Kate was awarded a Dame Commander of the Order of the British Empire (DBE) in 2021.
Timestamps
02:22 Kate Bingham's career journey
05:42 Precision medicine and disease modification
12:01 The future of healthcare and AI
14:18 Dementia discovery funds and new drugs
20:32 The challenges and rewards of venture capital
24:29 The Importance of constructive relationships in venture capital
30:37 Challenges and successes of the vaccine task force
40:32 Navigating political and public scrutiny
49:59 Women in science and leadership
Links
All About Business is brought to you by Reed Global. Learn more at: www.reed.com
This podcast was co-produced by Reed Global and Flamingo Media. If you’d like to create a chart-topping podcast to elevate your brand, visit Flamingo-media.co.uk